ReviewWorld journal of urology2025
The significance of endocannabinoid receptors and endocannabinoids in the lower urinary and genital tract.
Review in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe cannabinoid receptor (CB) signal transduction is a complex system that is relatively widespread in mammalian cells and tissues. By regulating the local levels and actions of other chemical signals, it can activate multiple cascades in different organs. Cannabinoid receptors and endocannabinoids are also present in the human lower urinary tract (LUT) and genital tract, including the urinary bladder, prostate, urethra, penile erectile tissue and seminal vesicles. The present review aims to give an overview on what has emerged from basic research and clinical approaches on the role of the endocannabinoid system (ECS) in the human lower urinary tract and reproductive tissues.
methodsThis review article highlights some key data from research into the cannabinoid system and its potential role in the control of micturition, reproductive functions and also dysfunctions of the lower urinary tract.
resultsWhile basic research findings on the ECS in reproductive tissues (penile erectile tissue, seminal vesicles) have not yet been supplemented by data from trials addressing clinical conditions such as erectile dysfunction (ED) and ejaculatory disorders (for example, premature ejaculation), targeting the ECS has been suggested as a pharmacological approach to treat disorders of bladder filling and storage functions.
conclusionDespite some preclinical data may favor a role of receptors, ligands and regulatory proteins of the ECS in the LUT, additional clinical evidence is required in order to support a significance of a modulation of the pathways stimulated by cannabinoid molecules in the treatment of dysfunctions of the lower urinary and genital tract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.